Contact us: +91 9550333722 040 - 40102781
Structured search
India
Choose your country
Different countries will display different contents
Try our best to find the right business for you.
My chemicalbook

Welcome back!

Homecompany(1R,2S)-2-(3,4-Difluorophenyl)cyclopropanamine (2R)-Hydroxy(phenyl)ethanoate 98%
(1R,2S)-2-(3,4-Difluorophenyl)cyclopropanamine (2R)-Hydroxy(phenyl)ethanoate
(1R,2S)-2-(3,4-Difluorophenyl)cyclopropanamine (2R)-Hydroxy(phenyl)ethanoate
(1R,2S)-2-(3,4-Difluorophenyl)cyclopropanamine (2R)-Hydroxy(phenyl)ethanoate

(1R,2S)-2-(3,4-Difluorophenyl)cyclopropanamine (2R)-Hydroxy(phenyl)ethanoate 98%

Price Get Latest Price
Packge 1MT1kg5kg10kg25kg
  • Min. Order:1MT
  • Time:2024-01-02

Product Details

  • Product Name(1R,2S)-2-(3,4-Difluorophenyl)cyclopropanamine (2R)-Hydroxy(phenyl)ethanoate
  • CAS No.376608-71-8
  • EINECS No.1308068-626-2
  • MFC17H17F2NO3
  • MW321.32
  • InChIKeyGUESUQPLVFMJIT-RUKVIUEPNA-N
  • AppearanceSolidWhite to Off-White
  • storage temp. under inert gas (nitrogen or Argon) at 2–8 °C
  • Melting point 161 °C

Company Profile Introduction

Our mission at VIDGAS is to provide our pharmaceutical, Bio pharma, Agrochemical, Food and Fine chemical customers with the highest quality SFC and HPLC purification and isolation solutions that market has to offer. With our 25 years of HPLC experience, we are able to provide variety of products with custom tailored answers for even most difficult separations. Our team of professional Chromatographers is available to assist in HPLC and SFC methods development solutions. Here at VIDGAS we are constantly innovating and pursuing the limits of HPLC and SFC.

Dr Duvvuri Subrahmanyam (shortly known as DS) has done his PhD from University of Hyderabad in 1989 in Synthetic Organic Chemistry with Prof. Goverdhan Mehta. Then he moved to US for his Post Doc fellow in Michigan State University and University of Pennsylvania for 4years from 1989 to 1993.

He Joined Dr Reddy’s Research Foundation (DRF) as Sr.Scientist in Medicinal chemistry Division in Feb 1993. He became Principal Scientist in the year of 1995 and then Associate Director in the year of 1999 before he left DRF in the year 2000. He worked in anti-cancer research area using natural products like 10—DAB, 14-DAB (related to taxol and taxotere),20(S)-Camptothecin, Podophyllotoxin, tryptanthrinetc, to make semi-synthetic analogs. He also worked in anti-infective research area and developed novel Oxazolidine analogs.

  • Since:2020-01-01
  • Address: plot no 1397 pragathi nagar Hyderabad
INQUIRY